Research Papers

25 of 128 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Management of IgE-mediated food allergy in the 21st century.
Cafarotti A; Giovannini M; Begìn P; Brough HA; Arasi S.
Clin Exp Allergy (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Paediatric asthma and non-allergic comorbidities: A review of current risk and proposed mechanisms.
Brew BK; Osvald EC; Gong T; Hedman AM; Holmberg K; Larsson H; Ludvigsson JF; Mubanga M; Smew AI; Almqvist C.
Clin Exp Allergy (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Anaphylaxis in Brazil between 2011 and 2019.
Tanno LK; Molinari N; Annesi-Maesano I; Demoly P; Bierrenbach AL.
Clin Exp Allergy (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Eosinophilic esophagitis: Immune mechanisms and therapeutic targets.
Khokhar D; Marella S; Idelman G; Chang JW; Chehade M; Hogan SP.
Clin Exp Allergy (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Neutrophil phenotypes in bronchial airways differentiate single from dual responding allergic asthmatics.
van der Burg N; Stenberg H; Ekstedt S; Diamant Z; Bornesund D; Ankerst J; Kumlien Georén S; Cardell LO; Bjermer L; Erjefält J; Tufvesson E.
Clin Exp Allergy (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Establishing subclasses of childhood eczema, their risk factors and prognosis.
Lopez DJ; Lodge CJ; Bui DS; Waidyatillake NT; Abramson MJ; Perret JL; Su JC; Erbas B; Svanes C; Dharmage SC; Lowe AJ.
Clin Exp Allergy (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Intralymphatic immunotherapy with one or two allergens renders similar clinical response in patients with allergic rhin…
Ahlbeck L; Ahlberg E; Björkander J; Aldén C; Papapavlou G; Palmberg L; Nyström U; Retsas P; Nordenfelt P; Togö T; Johansen P; Rolander B; Duchén K; Jenmalm MC.
Clin Exp Allergy (Unknown)
Published: 2022
4/6 Transparent
Registered Funding Declared
Burden of allergic disease among ethnic minority groups in high-income countries.
Jones CJ; Paudyal P; West RM; Mansur AH; Jay N; Makwana N; Baker S; Krishna MT.
Clin Exp Allergy (Unknown)
Published: 2022
2/6 Transparent
Leukocyte redistribution as immunological biomarker of corticosteroid resistance in severe asthma.
Cardoso-Vigueros C; von Blumenthal T; Rückert B; Rinaldi AO; Tan G; Dreher A; Radzikowska U; Menz G; Schmid-Grendelmeier P; Akdis CA; Sokolowska M.
Clin Exp Allergy (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Efficacy of N-acetyl aspartyl glutamic acid versus fluorometholone for treating allergic conjunctivitis in an environme…
de Blay F; Gherasim A; Domis N; Choual I; Bourcier T.
Clin Exp Allergy (Unknown)
Published: 2022
4/6 Transparent
Registered Funding Declared
Anti-phospholipid antibodies are elevated and functionally active in chronic rhinosinusitis with nasal polyps.
Eide JG; Wu J; Stevens WW; Bai J; Hou S; Huang JH; Rosenberg J; Utz P; Shintani-Smith S; Conley DB; Welch KC; Kern RC; Hulse KE; Peters AT; Grammer LC; Zhao M; Lindholm P; Schleimer RP; Tan BK.
Clin Exp Allergy (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Microbiota of the first-pass meconium and subsequent atopic and allergic disorders in children.
Kielenniva K; Ainonen S; Vänni P; Paalanne N; Renko M; Salo J; Tejesvi MV; Pokka T; Pirttilä AM; Tapiainen T.
Clin Exp Allergy (Unknown)
Published: 2022
4/6 Transparent
Data Funding Declared
Real-world efficacy of treatment with benralizumab, dupilumab, mepolizumab and reslizumab for severe asthma: A systemat…
Charles D; Shanley J; Temple SN; Rattu A; Khaleva E; Roberts G.
Clin Exp Allergy (Unknown)
Published: 2022
4/6 Transparent
Registered Funding Declared
Association between allergic sensitization and intestinal parasite infection in schoolchildren in Gqeberha, South Afric…
Brandt O; Wegenstein B; Müller I; Smith D; Nqweniso S; Adams L; Müller S; du Randt R; Pühse U; Gerber M; Navarini AA; Utzinger J; Labhardt ND; Schindler C; Walter C.
Clin Exp Allergy (Unknown)
Published: 2022
3/6 Transparent
Funding Declared
Type 2 immunity-driven diseases: Towards a multidisciplinary approach.
Hassoun D; Malard O; Barbarot S; Magnan A; Colas L.
Clin Exp Allergy (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Clinical and immunological evaluation of cat-allergic asthmatics living with or without a cat.
Wambre ER; Farrington M; Bajzik V; DeBerg HA; Ruddy M; DeVeaux M; Meier P; Robinson D; Cantor M; Huang C; Orengo JM; Wang CQ; Radin A.
Clin Exp Allergy (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
Incidence and risk factors for persistent symptoms in adults previously hospitalized for COVID-19.
Munblit D; Bobkova P; Spiridonova E; Shikhaleva A; Gamirova A; Blyuss O; Nekliudov N; Bugaeva P; Andreeva M; DunnGalvin A; Comberiati P; Apfelbacher C; Genuneit J; Avdeev S; Kapustina V; Guekht A; Fomin V; Svistunov AA; Timashev P; Subbot VS; Royuk VV; Drake TM; Hanson SW; Merson L; Carson G; Horby P; Sigfrid L; Scott JT; Semple MG; Warner JO; Vos T; Olliaro P; Glybochko P; Butnaru D; Sechenov StopCOVID Research Team.
Clin Exp Allergy (Unknown)
Published: 2021
3/6 Transparent
Registered Funding Declared
Poor understanding of allergen labelling by allergic and non-allergic consumers.
Holleman BC; van Os-Medendorp H; van den Bergh H; van Dijk LM; Linders YFM; Blom WM; Verhoeckx KCM; Michelsen-Huisman A; Houben GF; Knulst AC; Lentz LR.
Clin Exp Allergy (Unknown)
Published: 2021
3/6 Transparent
Data Funding Declared
Identifying key priorities for research to protect the consumer with food hypersensitivity: A UK Food Standards Agency …
Turner PJ; Andoh-Kesson E; Baker S; Baracaia A; Barfield A; Barnett J; Brunas K; Chan CH; Cochrane S; Cowan K; Feeney M; Flanagan S; Fox AT; George L; Gowland MH; Heeley C; Kimber I; Knibb R; Langford K; Mackie A; McLachlan T; Regent L; Ridd M; Roberts G; Rogers A; Scadding G; Stoneham S; Thomson D; Urwin H; Venter C; Walker M; Ward R; Yarham RAR; Young M; O'Brien J.
Clin Exp Allergy (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Subclasses of allergen-specific IgG: Serum IgG2 and IgG3 levels are not predicted by IgG1/IgG4 levels.
MacGlashan D; Alvarez-Arango S; Tversky J.
Clin Exp Allergy (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Inhibition of cow's milk allergy development in mice by oral delivery of β-lactoglobulin-derived peptides loaded PLGA n…
Liu M; Thijssen S; van Nostrum CF; Hennink WE; Garssen J; Willemsen LEM.
Clin Exp Allergy (Unknown)
Published: 2021
2/6 Transparent
Funding Declared
Dupilumab suppresses type 2 inflammatory biomarkers across multiple atopic, allergic diseases.
Hamilton JD; Harel S; Swanson BN; Brian W; Chen Z; Rice MS; Amin N; Ardeleanu M; Radin A; Shumel B; Ruddy M; Patel N; Pirozzi G; Mannent L; Graham NMH.
Clin Exp Allergy (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
Biomarkers for predicting response to aspirin therapy in aspirin-exacerbated respiratory disease.
Tyrak KE; Pajdzik K; Jakieła B; Kupryś-Lipińska I; Ćmiel A; Kacorzyk R; Trąd G; Kuna P; Sanak M; Mastalerz L.
Clin Exp Allergy (Unknown)
Published: 2021
3/6 Transparent
Funding Declared
Treating severe asthma: Targeting the IL-5 pathway.
Principe S; Porsbjerg C; Bolm Ditlev S; Kjaersgaard Klein D; Golebski K; Dyhre-Petersen N; van Dijk YE; van Bragt JJMH; Dankelman LLH; Dahlen SE; Brightling CE; Vijverberg SJH; Maitland-van der Zee AH.
Clin Exp Allergy (Unknown)
Published: 2021
1/6 Transparent
Adverse reactions to COVID-19 vaccines: A practical approach.
Rutkowski K; Mirakian R; Till S; Rutkowski R; Wagner A.
Clin Exp Allergy (Unknown)
Published: 2021
2/6 Transparent